Evaluating the relationship between variance in enzyme expression and toxicant concentration in health risk assessment

Human and Ecological Risk Assessment

Volumn 10, Issue 1 SPEC. ISS., 2004, Pages 39-55

  Lipscomb, John C ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Biotransformation; Clearance; Enzyme variance; Pharmacokinetics; Risk assessment; Uncertainty factors; Xenobiotics

Indexed keywords

ANIMALIA;

EID: 1642336265     PISSN: 10807039     EISSN: None     Source Type: Journal    
DOI: 10.1080/10807030490280945     Document Type: Conference Paper

References (25)

1. Allen BC and Fisher JW. 1993. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal 13:71-86
2. Buckpitt A, Boland B, Isbell M, et al. 2002. Naphthalene-induced respiratory tract toxicity: Metabolic mechanisms of toxicity. Drug Metab Rev 34:791-820
3. Cogliano VJ, Scott CS, Caldwell JC, et al. 2001. Trichloroethylene: Using new information to improve the cancer characterization. Hum Ecol Risk Assess 7:755-66
4. Dorne JLCM, Walton K, and Renwick AG. 2003. Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food Chem Toxicol 41:201-24
5. Farrell G. 1999. Effects of disease on expression and regulation of CYPs. Mol Aspects Med 20:55-70
6. Hassett C, Laurenzana EM, Sidhu JS, et al. 1998. Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures. Biochem Pharmacol 55:1059-69
7. IPCS (International Programme on Chemical Safety). 2001. Guidance Document for the Use of Data in Development of Chemical-Specific Adjustment Factors (CSAFs) for Interspecies Difference and Human Variability in Dose/Concentration-Response Assessment, WHO/PCS/01.4. World health organization, Geneva, Switzerland. Downloaded from www at: http://www.ipcsharmonize.org/csaf- intro.html
8. Kato R and Yamazoe Y. 1992. Sex-specific cytochrome P-450 as a cause of sex- and species-related differences in drug toxicity. Toxicol Lett 64/65:661-7
9. Kedderis GL. 1997. Extrapolation of in vitro enzyme induction data to humans in vivo. Chem Biol Interact 107:109-21
10. Lampe JW and Peterson S. 2002. Brassica, biotransformation and cancer risk: Genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr 132:2991-4
11. Lash LH, Fisher JW, Lipscomb JC, et al. 2000. Metabolism of trichloroethylene. Environ Health Perspect 108(Suppl 2):177-200
12. Lipscomb JC and Kedderis GL. 2002. Incorporating human interindividual biotransformation variance in health risk assessment. Sci Tot Environ 288:13-21
13. Lipscomb JC, Garrett CM, and Snawder JE. 1997. Cytochrome P450-dependent metabolism of trichloroethylene: Interindividual differences in humans. Toxicol Appl Pharmacol 142: 311-8
14. Lipscomb JC, Fisher JW, Confer PD, et al. 1998a. In vitro to in vivo extrapolation for trichloroethylene metabolism in humans. Toxicol Appl Pharmacol 152:376-87
15. Lipscomb JC, Garrett CM, and Snawder JE. 1998b. Use of kinetic and mechanistic data in species extrapolation of bioactivation: Cytochrome P-450 dependent trichloroethylene metabolism at occupationally relevant concentrations. J Occup Health 40:110-7
16. Lipscomb JC, Teuschler LK, Swartout JC, et al. 2003a. Variance of microsomal protein and cytochrome P450 2E1 and 3A forms in adult human liver. Toxicol Mech Methods 13:45-51
17. Lipscomb JC, Teuschler LK, Swartout J, et al. 2003b. The impact of cytochrome P450 2E1-dependent metabolic variance on a risk relevant pharmacokinetic outcome in humans. Risk Analysis 23:1221-38
18. Okey AB. 1990. Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 45:241-98
19. Roe AL, Warren G, Hou G, et al. 1998. The effect of high-dose endotoxin on CYP3A2 expression in the rat. Pharmacol Res 15:1603-8
20. Roe AL, Howard G, Blouin R, et al. 1999. Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice. Int J Obes Relat Metab Disord 23:48-53
21. Scott CS and Cogliano VJ. 2000. Trichloroethylene Health Risks - State of the science. Environ Health Perspect 108(Suppl 2):159-60
22. Snawder JE and Lipscomb JC. 2000. Interindividual Variance of Cytochrome P450 Forms in Human Hepatic Microsomes: Correlation of Individual Forms with Xenobiotic Metabolism and Implications in Risk Assessment. Regul Toxicol Pharmacol 32:200-9
23. USEPA (US Environmental Protection Agency). 2002. Review of Draft Trichloroethylene Health Risk Assessment: Synthesis and Characterization: An EPA Science Advisory Board Report. EPA-SAB-EHC-03-002, December, 2002. EPA Science Advisory Board, Washington, DC. Online at: http://www.epa.gov/sab/pdf/ehc03002. pdf
24. Yin S-J, Liao C-S, Wu C-W, et al. 1997. Human stomach alcohol and aldehyde dehydrogenases: Comparison of expression pattern and activities in alimentary tract. Gastroenterol 112:766-75
25. Yoshihara E, Ameno K, Nakamura K, et al. 2000. The effects of the ALDH2*1/2, CYP2E1 C1/C2 and C/D genotypes on blood ethanol elimination. Drug Chem Toxicol 23:371-9